文献速递慢性肾脏病

HDL胆固醇、LDL胆固醇和甘油三酯作为CKD危险因素:孟德尔随机化研究

HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
PubMed 文献 · Am J Kidney Dis · 2017-07-26

该研究采用两样本孟德尔随机化分析,利用全球脂质遗传学联盟(n=188,577)和CKD遗传学联盟(n=133,814)的数据,评估遗传决定的血脂浓度与肾功能指标的因果关联。结果显示,遗传性较高的HDL胆固醇与更好的肾功能(eGFR更高、eGFR<60风险更低)因果相关,而LDL胆固醇和甘油三酯未显示与任何肾脏指标有因果关联。

要点

  • 遗传性较高的HDL胆固醇与eGFR升高及eGFR<60风险降低因果相关。
  • LDL胆固醇和甘油三酯浓度与肾功能指标无因果关联证据。
  • 甘油三酯的初始关联由GCKR基因多效性变异驱动,排除后消失。

核心结论

  • 遗传性较高的HDL胆固醇浓度与更好的肾功能因果相关,LDL胆固醇或甘油三酯无此关联。

研究设计与样本

  • 两样本孟德尔随机化分析,脂质遗传变异数据来自全球脂质遗传学联盟(n=188,577),肾脏结局数据来自CKD遗传学联盟(n=133,814)。

主要发现

  • HDL胆固醇每升高17 mg/dL,eGFR升高0.8%(95% CI 0.4%-1.3%;P=0.004),eGFR<60风险降低(OR 0.85;95% CI 0.77-0.93;P<0.001)。
  • LDL胆固醇浓度与任何肾脏疾病指标均无因果关联证据。
  • 遗传性较高的甘油三酯初始与较高eGFR相关,但由GCKR基因单一致多效性变异驱动,排除后无关联。

关键数值与推荐

  • HDL胆固醇每升高17 mg/dL对应eGFR升高0.8%(95% CI 0.4%-1.3%;P=0.004)及eGFR<60的OR 0.85(95% CI 0.77-0.93;P<0.001)。

临床怎么用

  • 提示HDL胆固醇可能是CKD预防的潜在干预靶点,但需等待HDL胆固醇干预试验的CKD结局分析验证。

局限性

  • 缺乏个体患者水平的表型和基因型信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglyceride concentrations are heritable risk factors for vascular disease, but their role in the progression of chronic kidney disease (CKD) is unclear. STUDY DESIGN: 2-sample Mendelian randomization analysis of data derived from the largest published lipid and CKD studies. SETTING & PARTICIPANTS: Effect of independent genetic variants significantly associated with lipid concentrations was obtained from the Global Lipids Genetics Consortium (n=188,577), and the effect of these same variants on estimated glomerular filtration rate (eGFR), CKD (defined as eGFR<60mL/min/1.73m2), and albuminuria was obtained from the CKD Genetics Consortium (n=133,814). FACTOR: Using conventional, multivariable, and Egger Mendelian randomization approaches, we assessed the causal association between genetically determined lipid concentrations and kidney traits. OUTCOME: eGFR, dichotomous eGFR<60mL/min/1.73m2, and albuminuria. RESULTS: In multivariable analysis, a 17-mg/dL higher HDL cholesterol concentration was associated with an 0.8% higher eGFR (95% CI, 0.4%-1.3%; P=0.004) and lower risk for eGFR<60mL/min/1.73m2 (OR, 0.85; 95% CI, 0.77-0.93; P<0.001), while Egger analysis showed no evidence of pleiotropy. There was no evidence for a causal relationship between LDL cholesterol concentration and any kidney disease measure. Genetically higher triglyceride concentrations appeared associated with higher eGFRs, but this finding was driven by a single pleiotropic variant in the glucokinase regulator gene (GCKR). After exclusion, genetically higher triglyceride concentration was not associated with any kidney trait. LIMITATIONS: Individual patient-level phenotype and genotype information were unavailable. CONCLUSIONS: 2-sample Mendelian randomization analysis of data from the largest lipid and CKD cohorts supports genetically higher HDL cholesterol concentration as causally associated with better kidney function. There was no association between genetically altered LDL cholesterol or triglyceride concentration and kidney function. Further analysis of CKD outcomes in HDL cholesterol intervention trials is warranted.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Lanktree MB, Thériault S, Walsh M, et al. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study. Am J Kidney Dis. 2017. PMID: 28754456. doi:10.1053/j.ajkd.2017.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。